Tuesday, Mar 26, 2024 · SEC filings
What the smart money revealed on Mar 26
552 insider filings came in. We hid 48 planned (10b5-1) sellers and 397 people whose filings were routine, like grants and tax withholding.
KKR FS Income Trust Select President and CEO Michael Forman bought $5.71M
228,571 shares on the open market. Not a grant or an option exercise. Their past buys: 0 of 4 checked quarters beat the typical stock 6 months later.
Grocery Outlet Holding (GO) Director Erik Ragatz bought $1.03M
36,500 shares on the open market. Not a grant or an option exercise. Their past buys: 2 of 6 checked quarters beat the typical stock 6 months later.
Universal Biosensors (UBI) Director Craig Coleman bought $200K
1M shares on the open market. Not a grant or an option exercise.
Entrada Therapeutics (TRDA) Director Peter Kim bought $123K
9,048 shares on the open market. Not a grant or an option exercise.
ConocoPhillips (COP) Chairman and CEO Ryan Lance sold $76.4M
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 6,780 shares directly.
AutoZone (AZO) Executive Chairman William Rhodes III sold $59.8M
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 30,714 shares directly.
Samsara (IOT) Director Hemant Taneja sold $2.55M
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 18 more real buys
Show 58 more real sales
13F season
Holdings as of Dec 31, 2023 were due Feb 14
49 funds have filed. 40 filed for the quarter before.
Biggest real insider buys, Mar 20–26
Open-market buys by officers and directors, filed in the 7 days up to Mar 26.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.